BULLOUS PEMPHIGOID
Clinical trials for BULLOUS PEMPHIGOID explained in plain language.
Never miss a new study
Get alerted when new BULLOUS PEMPHIGOID trials appear
Sign up with your email to follow new studies for BULLOUS PEMPHIGOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for blistering skin disease: drug may reduce steroid dependence
Disease control CompletedThis study tested a drug called dupilumab in 106 adults with bullous pemphigoid, a painful blistering skin condition that mostly affects older people. The goal was to see if dupilumab could help patients stop taking steroids and keep the disease under control. Results showed whet…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2, PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:43 UTC
-
One-Dose hope for severe blistering skin disease
Disease control CompletedThis study tested whether a single cycle of the drug rituximab could control bullous pemphigoid, a painful blistering skin condition. Researchers followed 18 adults for up to 2 years to see if the treatment worked and was safe. The goal was to reduce the need for long-term steroi…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Promising new drug targets blistering skin disease in elderly
Disease control CompletedThis study tested a new drug called avdoralimab, given with strong steroid cream, for bullous pemphigoid—a painful blistering skin condition common in people over 70. Fifteen participants received the combination to see if it helped clear blisters and itching faster than steroids…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New shot could tame blistering skin disease and cut steroid use
Disease control CompletedThis study tested a drug called efgartigimod in 98 adults with moderate to severe bullous pemphigoid, a condition that causes painful blisters and itching. The goal was to see if the drug could help people achieve complete remission (no new blisters, healed skin, no itching) whil…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New combo therapy for blistering skin disease may be easier and safer
Disease control CompletedThis study tested whether adding methotrexate to topical steroids for bullous pemphigoid works as well as using topical steroids alone. 322 adults with the disease took part. The goal was to see if the combination treatment is equally effective but easier to manage and with fewer…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 18, 2026 11:58 UTC
-
Steroid cream surprise: study probes hidden fluid shifts in skin disease
Knowledge-focused CompletedThis study looked at whether a very strong steroid cream (clobetasol propionate) causes fluid retention in 30 adults with bullous pemphigoid, a blistering skin condition. Researchers measured changes in body water using a special scale over 30 days. The goal was to understand if …
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 26, 2026 07:43 UTC